Investors are showcasing diverse responses after IQVIA Holdings (IQV) demonstrated impressive earnings and a strong, organic revenue growth. Over the past five years, those invested in IQVIA have seen returns of up to 35%. However, some significant stockholders, such as Invesco Ltd and M&T Bank Corp have reduced their holdings in the company. On the flip side, others such as Panagora Asset Management Inc and Brandes Investment Partners LP are increasing their stakes. Our experts believe that IQVIA's high return on equity (ROE) and its victorious earnings beat against consensus estimates contribute to its rise. The company is now adopting AWS as the preferred cloud provider for its new AI platform. Lastly, the partnership with Kexing Biopharm aims to enhance drug development. Overall, despite decreases in certain stakeholder holdings, IQVIA's growth potential remains promising.
Iqvia Holdings IQV News Analytics from Fri, 21 Mar 2025 07:00:00 GMT to Sat, 06 Dec 2025 14:33:50 GMT -
Rating 7
- Innovation 3
- Information 9
- Rumor -2
